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Mitochondrial diseaseIn the absence of a comprehensive experimentally derived mitochondrial proteome, several bioinformatic
approaches have been developed to aid the identification of novel mitochondrial disease genes within
mapped nuclear genetic loci. Often, many classifiers are combined to increase the sensitivity and specificity of
the predictions.
Here we show that the greatest sensitivity and specificity are obtained by using a combination of seven
carefully selected classifiers. We also show that increasing the number of independent prediction methods
can paradoxically decrease the accuracy of predicting mitochondrial localization. This approach will help to
accelerate the identification of new mitochondrial disease genes by providing a principled way for the
selection for combination of appropriate prediction methods of mitochondrial localization of proteins.
© 2011 Elsevier B.V. and Mitochondria Research Society. All rights reserved.1. Introduction
Mitochondrial disorders are a major cause of human disease
affecting at least 1 in 5000 of the population (Schaefer et al., 2008;
Skladal et al., 2003). The clinical presentation of mitochondrial
disorders is highly variable but often leads to a progressive, incurable
multi-system disease causing substantial morbidity and often result-
ing in premature death (DiMauro and Schon, 2003). Oxidative
phosphorylation (OXPHOS) is carried out by the mitochondrial
respiratory chain, which is composed of over 100 polypeptide
subunits arranged in five enzyme complexes on the inner mitochon-
drial membrane. Thirteen of the proteins involved OXPHOS are
synthesized within the mitochondrion from mitochondrial DNA
(mtDNA), and mtDNA mutations are a major cause of OXPHOS
disease especially in adult life (Schaefer et al., 2008). However, the
vast majority of OXPHOS subunits are synthesized from nuclear gene
transcripts, along with a large number of proteins involved in
mitochondrial biogenesis, mtDNA maintenance and expression, and
respiratory chain assembly (Spinazzola and Zeviani, 2007).
Over ~50% of OXPHOS disorders are present in childhood with
sporadic or autosomal recessive disease. Although the underlying
gene defect can be indentified in many cases, the precise molecular: +44 191 241 8666.
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disease gene in unexplained OXPHOS disease has major implications,
enabling accurate genetic counselling and prenatal diagnosis, and
often revealing totally new mechanisms of disease (Bourdon et al.,
2007; Bykhovskaya et al., 2004; Coenen et al., 2004; Mandel et al.,
2001; Saada et al., 2003). Standard approaches include homozygosity
mapping (Elpeleg et al., 2005; Hoefs et al., 2008; Spinazzola et al.,
2006) and systematic re-sequencing (Mandel et al., 2001; Saada et al.,
2003), or microcell mediated chromosomal transfer (Zhu et al., 1998)
aimed at correcting a cellular biochemical defect. Although potentially
very powerful, the identification of new disease genes remains hugely
time consuming and very expensive, even with current sequencing
platforms. This places constraints on the number of families that can
be comprehensively investigated, and there is a need to develop new
techniques which streamline the approach.
Several bioinformatic methods have been developed to identify
putative mitochondrial proteins within a candidate interval, including
N-terminal targeting sequence prediction, sequence homology, and
phylogenetic relationships with knownmitochondrial proteins. These
tools have been combined with experimentally derived data sets
including gene co-expression profiles and species homology using
machine learning (Kumar et al., 2006; Prokisch et al., 2006), Bayesian
(Calvo et al., 2006) and Hidden Markov (Kumar et al., 2006)
techniques. The general approach is to identify parameters in the
combined dataset that distinguish mitochondrial and non-mitochon-
drial proteins in an experimentally derived dataset, and to apply these
algorithms to proteins of unknown function. Using this approach, thell rights reserved.
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et al., 2008), corresponding to ~1% of nuclear gene transcripts.
From first principles, the aim of the bioinformatic approach is to
increase the specificity of predicting that a given protein is likely to be
mitochondrial (correctly identifying true non-mitochondrial pro-
teins), without unduly compromising the sensitivity (correctly
identifying true mitochondrial proteins). This has been achieved by
combining several bioinformatic prediction tools with an experimen-
tally derived data set of known mitochondrial proteins (Calvo et al.,
2006; Pagliarini et al., 2008). This is based on the assumption that the
incorporation of additional independent data sets (i.e. independent
predictions of mitochondrial localization of proteins) will inevitably
improve the accuracy, including parameters derived from experi-
mentally-based data sets. However, the finite size of the mitochon-
drial proteome places theoretical constraints on this strategy. As a
general rule of thumb, a reliable prediction algorithm can only be
derived using a set of known mitochondrial and non-mitochondrial
proteins if the number of parameters is at least ~100 fold less than the
size of the data set (Baum and Haussler, 1989; Hastie et al., 2009).
Thus, predictions based on the analysis of N5 independent prediction
methods are likely to be unreliable (each method considered as a
parameter of the combined method), and if carried out, the accuracy
of the predictions is likely to vary considerably each time the work is
carried out, questioning the reliability of published prediction tools
(Hastie et al., 2009).2. Methods
The performance of the different combinations of bioinformatic
prediction tools was evaluated using 6352 known non-mitochondrial
proteins and 467 known mitochondrial proteins extracted from
SwissProt (www.ebi.ac.uk/swissprot/) with clear experimental evi-
dence of sub-cellular localization (Available at http://www.staff.ncl.
ac.uk/peter.andras/supplinfo_lythgowetal/). All of the prediction tools
were evaluated using the same test proteins. The proteins were
matched to the parameters derived from the eleven prediction tools
listed in Table 1 (Calvo et al., 2006), with the addition of MitoProt and
SubLoc (Claros and Vincens, 1996; Hua and Sun, 2001).
When combined, these resources address the issue of mitochon-
drial localization from several different angles, including: N-terminal
targeting sequence (TargetP) (Bannai et al., 2002); protein domains
(Pfam) (Guda et al., 2004); Cis-regulatory motifs in human/mouse
orthologues (Calvo et al., 2006); Saccharomyces cerevisiae homology
(Calvo et al., 2006); Rickettsia prowazekii ancestry (Calvo et al., 2006);
coexpression with known mitochondrial genes in human/mouse
tissue atlases (Calvo et al., 2006); mouse mitochondria detected in
brain, heart, liver and kidney; transcriptional induction during
mitochondrial biogenesis (Calvo et al., 2006); and MITOPRED (HuaTable 1
Identifier Method Prediction tool/data set
1 Protein domain Pfam domain found only in eukaryotic
mitochondrial proteins
2 Cis motif Errα motif in human/mouse promoters
3 Yeast homology S. cerevisiae mitochondrial orthology
4 MS/MS Mouse mitochondria (brain, heart, liver,
and kidney)
5 Induction Difference in PGC-1α induced gene expression
6 MITOPRED Pfam domain
7 Targeting signal TargetP on human/mouse orthologues
8 Ancestry R. prowazekii orthology
9 Coexpression Coexpression with known human/mouse
mitochondrial genes
10 Targeting signal MitoProt II
11 Amino acid
composition
SubLocand Sun, 2001); which is a genome-scale method for prediction of
nucleus-encoded mitochondrial proteins. Although this is not a
comprehensive list of the available prediction tools, these are amongst
those most commonly used, and are generally accepted to perform at
a high level. Using a larger group of prediction tools would
compromise the approach, given the limited size of the test set of
known mitochondrial and non-mitochondrial proteins.
Bioinformatic analysis was carried out using a workflow in the
Taverna workbench (Hull et al., 2006; Oinn et al., 2006a), enabling
automated large scale in-silico experiments using distributed services
on the world-wide-web (Fig. S1) and incorporating a support vector
machine (SVM, svm_light v6.02, http://svmlight.joachims.org/). The
SVM approach has the advantage of incorporating an unbiased,
objective weighting of the most discriminant component variables.
The parameters for the SVM learning algorithm were optimized to
yield the highest accuracy of prediction with the lowest number of
support vectors. An accuracy of 95.76% was achieved using this
algorithm the following parameters: -c 10 -b 0 -t 2 -g 0.1 -e 1.0; where
c is the margin of tolerance to error, with increasing values increasing
tolerance to error; and g is the width of the Gaussian associated with
support vectors, with decreasing values decreasing the range of
detection of similarity with support vectors.
Standard statistical methods were used to determine the mean,
standard deviation, sensitivity and specificity, based on the Gaussian
distribution. The false discovery rate (FDR) is the proportion of all the
false predictions generated during the analysis FDR=FP/(FP+TP).
FP=false positives. TP=true positives. A difference in the proportion
of mitochondrial and non-mitochondrial proteins in training set when
compared to the actual proportion in the human genome can bias the
FDR. This can be accounted for by scaling the FDR based on the
estimated number of mitochondrial proteins encoded by the nuclear
genome (1500 of 21,000 genes). Using this approach, the corrected
FDR, cFDR=(1-specificity) / (1− specificity+sensitivity× [1500/
21,000]), where specificity=TN/(TN+FP), SN=TP/(TP+FN), and
TN=true negatives, FN=false negatives.
3. Results
3.1. Increasing the number of prediction tools can reduce the accuracy of
predicted mitochondrial localization
We systematically studied all possible combinations (n=2047) of
the eleven different prediction tools, using ~90% of the full data set as
training data and ~10% as testing data. From an overall dataset of 6819
candidate proteins (467 mitochondrial and 6352 non-mitochondrial
extracted from the Swiss-Prot database using specific localization
filters, the complete list is available at http://www.staff.ncl.ac.uk/
peter.andras/supplinfo_lythgowetal/), 730 were extracted from the
database at random to form the test set (100 mitochondrial and 630
non-mitochondrial), leaving 6089 candidates for training. A support
vector machine (SVM) was trained and tested 100 times for each one
of the 2047 possible combinations of the eleven prediction para-
meters. Each run used a different randomly selected training and test
set, allowing calculation of the mean and standard deviation of
sensitivity and specificity values. The prediction results were obtained
after minimizing the number of support vectors to b10% of the
training data set. Different combinations of the prediction tools were
ranked based upon the mean specificity and independently for the
mean sensitivity, for 100 independent SVM training runs using
different randomly selected training and test sets (Fig. 1).
The mean specificity of the SVM runs was high (N98%), but there
was considerable variability between individual prediction tools and
also between different combinations of prediction tools when
combinations of b4 were chosen (Fig. 2a). A small number of
prediction tools also led to considerable variability in the sensitivity
of predictions (Fig. 2b). Increasing the number of prediction tools
Fig. 1. Sensitivity of different combinations of prediction tools in rank order. Left hand=detail of the top 100 combinations.
Fig. 2. Range of mean (a) specificity and (b) sensitivity values for different
combinations (n=2047) of the eleven different prediction tools. Horizontal bar=
mean, box=standard deviation, whiskers=range.
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compromising the specificity (Fig. 2a).
However, increasing the number of tools beyond seven led to a
decrease in mean sensitivity. Similar results were obtained for the
derived false discovery rate (FDR), and corrected false discovery rate
(cFDR) which incorporates prior probabilities in the calculations
(Calvo et al., 2006). These findings show that increasing the number of
prediction methods does not always lead to a more reliable combined
prediction of mitochondrial localization.
3.2. Identifying the best prediction tools
To establish which tools improved the specificity and sensitivity of
a prediction, we determined the probability of any one tool being
involved in a prediction with a given specificity and sensitivity (Fig. 3;
see figure legend for a detailed explanation). Although each
prediction tool was equally likely to lead to a high specificity
(Fig. 3a and b), this was not the case for sensitivity, where specific
prediction tools were far more likely to be involved in predictions
with a high sensitivity (Fig. 3c). MITODOMAIN, TargetP and
MITOPRED were consistently associated with high sensitivity predic-
tions, whilst the R. prowazekii orthology (ancestry) was associated
with a lower sensitivity (Fig. 3d).
Careful scrutiny of the whole result set ranked from highest to
lowest sensitivity (Fig. 1) confirmed these findings. The poor
performance of the R. prowazekii orthology is probably due to two
factors — first, the limited number of orthologous proteins found in
humans and R. prowazekii, and second, the poor overall homology
between mitochondria and R. prowazekii which are distantly related
but share a common ancestor. The high performance of combinations
including MITODOMAIN, TargetP and MITOPRED reflects the comple-
mentarity of the three bioinformatic approaches, even though two are
Fig. 3. The contribution of each prediction tool to mean specificity (a and b); and mean sensitivity (c and d) for 100 training and test runs of the SVM. In this figure, “probability”
refers to the proportion of combinations where a specific prediction tool contributed to a result with a given specificity and sensitivity. (a) Heat contour plot showing the probability
of a specific tool or data set in contributing to a given level of specificity. Red=high probability, yellow=low probability. (b) Probability of each prediction tool contributing to a
given level of specificity for the top 100 combinations. (c) Heat contour plot showing the probability of a specific tool in contributing to a given level of sensitivity. Red=high
probability, yellow=low probability. (d) Probability of each prediction tool contributing to a given level of sensitivity for the prediction tools generating the top 100mean sensitivity
values.
Fig. 4. Relationship between sensitivity and specificity for the2047different combinations
of the prediction tools. Color code=the number of prediction tools incorporated in the
SVM prediction. Note the disproportionate axes.
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one on the N-terminal mitochondrial targeting sequences. Combina-
tion with four other prediction tools was required to achieve optimal
sensitivity and specificity.
3.3. Predicting the mitochondrial proteome
To determine the most effective combination of prediction
methods we compared the sensitivity and specificity for all 2047
combinations in (Fig. 4). Data points closest to the top right hand
corner, corresponding to the best overall prediction of mitochondrial
localization, were made with a combination of seven or eight tools.
Incorporating a greater number of prediction tools led to a reduction
in both sensitivity and specificity, confirming our earlier findings. The
highest sensitivity was obtained when the following four parameters
were not included the algorithm, including two based on experimen-
tally derived data sets: yeast homology, difference in gene expression
during mitochondrial biogenesis induced by PGC-1α, R. prowazekii
orthology, and co-expression with known mitochondrial genes in
human/mouse tissue atlases. The mean sensitivity using the best
combination of seven prediction tools (64.14, SD=5 .22) was
significantly greater than the mean sensitivity using all 11 prediction
tools (52.51, SD=5.80). Using this tool we carried out a comprehen-
sive genome-wide analysis of all available human transcripts
(n=37,435) from 22,258 genes available the Ensembl Genome
browser to determine the predicted human mitochondrial proteome
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lythgowetal/). 709 transcripts from 603 genes were predicted to
localize to the mitochondrial compartment.
4. Discussion
The poor performance of R. prowazekii orthologues in isolation is
well known (Calvo et al., 2006), but the work presented here shows
that the incorporation of R. prowazekii data is actually detrimental to
the process of human mitochondrial protein localization (Fig. 3d).
This is probably because of the poor sequence conservation between
evolutionary diverse species, which include yeast. Although much
more is known about the yeast mitochondrial proteome (Andreoli et
al., 2004), our observations show that this has limited relevance for
the identification of putative human mitochondrial proteins, many of
which are likely to have evolved after the evolutionary divergence.
From first principles, the integration of data sets from lower
organisms in an integrated bioinformatic prediction will thus
inevitably restrict the sensitivity of detection. Our analysis shows
that the inclusion of these data sets does not, however, increase
specificity— providing a strong argument for excluding them from an
integrated prediction approach. We were surprised that co-expres-
sion datasets, including those induced by PGC-1α, also did not
substantially improve the combined prediction. This could be due to
the limited number of genes incorporated in genome-wide array
studies, which again would limit sensitivity without increasing
specificity.
The same pattern was observed following the addition of further
experimentally derived predictions of mitochondrial localization. For
example, adding a log-likelihood prediction of mitochondrial locali-
zation based on subtractive MS/MS following mitochondrial enrich-
ment (17) to the 11 prediction methods (Table 1), produced a
combined mean prediction sensitivity of 50.89 (SD=4.54) and
combined mean specificity of 98.89 (SD=0.44). This was not
significantly different from the mean predictions without the
subtractive MS/MS enrichment. However, removing the four predic-
tion tools shown by our previous analysis to compromise sensitivity
(Fig. 3) improved the prediction (mean sensitivity=69.87, SD=4.40;
mean specificity=99.23, SD=0.34). This prediction was not signif-
icantly different from the best 7 predictors without the subtractive
MS/MS enrichment, but it further demonstrates the importance of
selecting the optimum combination of prediction tools based on
systematic analysis.
Even with the best available combination of prediction tools, there
was considerable variability in the sensitivity of the prediction each
time themachine learning tool was used (Fig. S2), a feature not shown
in previous reports. Although there was a general trend towards a
decreased SD with combinations of more prediction tools, and higher
sensitivity tended to be associated with a lower variability (Fig. S3),
this relationshipwas not strong and themajority of predictions had an
SD of ~5%. This means that, even for the best combination, the 95%
confidence intervals for the sensitivity of predicted mitochondrial
localization were ±10% of the mean value, highlighting the draw-
backs of even the most optimal bioinformatic predictions. This is
probably why the size of the mitochondrial proteome predicted by
our approach is smaller than previously published estimates.
Our approach differs from previous attempts to bioinformatically
define the mitochondrial proteome in several respects. First, SVM
performance was explicitly optimized to reduce the number of
support vectors to an acceptable level (Hastie et al., 2009). If the
number of support vectors is greater than ~10% of the number of
proteins in the test set, then tests of SVM performance give an
impression of artificially high performance which is due to the
parameters being closely tailored to the training set (overfitting). This
drastically reduces the predicting capability for unknown proteins.
Second, our conclusions are based on a rigorous statistically-basedcomparison of each prediction tool. Considerable variation between
each prediction run raises the possibility that previously published
combinations of predictors reported to have high sensitivity and
specificity values may be spurious results. Such combinations may
perform poorly over several repeated runs with independently
sampled data sets. Thirdly, by developing a web-based workflow to
operate the SVM, our tool will constantly update the predictions as the
component prediction methods themselves improve, and the number
of known human proteins increases. Thus, the list of mitochondrial
proteins will be constantly revised, including revisions to the human
genome sequence. This also provides the capacity to incorporate
genomic variation in the predictions with increasing depth of genome
re-sequencing. These combined features will accelerate the reliable
identification of human disease genes responsible for novel mito-
chondrial disorders, providing a molecular diagnosis for families, and
revealing new disease mechanisms.
4.1. Conclusion
The identification of a comprehensive mitochondrial proteome
would be extremely advantageous both to the molecular diagnosis of
mitochondrial diseases and to furthering our understanding of the
complex interplay between these two genomes. In recent years
several bioinformatic approaches have been developed to aid the
identification of novel mitochondrial disease genes, many of which
combine a number of independent prediction tools.
In this study we have demonstrated that careful selection of
mitochondrial classifiers yields increased sensitivity and specificity
but, perhaps more importantly, increasing the number of indepen-
dent prediction methods can paradoxically decrease the accuracy of
predicting mitochondrial localization.
4.2. Availability
Both the programs test data sets, and genome-wide predictions of
mitochondrial localization are freely available at http://www.staff.ncl.
ac.uk/peter.andras/supplinfo_lythgowetal/.
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